5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Ajanta Pharma Ltd.

•
ajantapharma.comBSE: 532331NSE: AJANTPHARM
Market Cap₹ 44,235 Cr.
Current Price
High / Low₹ 3,796 / 2,330
Stock P/E39.0
Book Value₹ 389
Price to Book7.74
Dividend Yield0.79 %
ROCE32.7 %
ROE25.4 %
Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 32.6%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 24.7%
  • Company has consistently been profitable over the last 5 years
  • Latest quarter profit grew 30.9% YoY, showing strong momentum
  • Company has been maintaining a healthy dividend payout of 33.1%

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Promoter holding has decreased over last 2 years: -2.8pp
  • Total debt has risen sharply - up 8084.9% year on year
  • Stock is trading at 7.7x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTYM150MOMNTM50NIFTY PHARMANIFTYLARGEMIDCAP250NIFTYMIDCAP150NIFTY MIDCAP 150
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.AJANTPHARM3539.9538.9844234.870.79334.2230.891625.9624.8232.6726.05
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
1,0211,0281,1051,0541,1451,1871,1461,1701,3031,3541,3751,4221,626
7507387917768158758258739511,0269931,0881,250
Operating Profit271291314278330311321297351328382333376
OPM %26.57%28.26%28.42%26.40%28.85%26.22%27.99%25.39%26.97%24.22%27.80%23.45%23.12%
32211436261930182659256171
Interest1222168653523
Depreciation33343434343436404143444544
Profit before Tax269276291278322290307269331341359347447
Tax %22.64%29.22%27.80%27.09%23.70%25.41%24.24%16.39%22.89%23.66%23.66%23.17%25.20%
Net Profit0000246216233225255260274267334
16.5315.5116.6816.1019.5417.2718.6018.0020.4420.8321.9121.3526.75

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,9832,1262,0552,5882,8903,3413,7434,2094,6485,4535,776
1,2961,4671,4891,9051,8912,4122,9593,0373,3894,0584,357
Operating Profit6876585666839999297831,1721,2601,3951,419
OPM %34.63%30.97%27.56%26.40%34.56%27.81%20.93%27.85%27.10%25.58%24.57%
2424218826116998594172217
Interest1011281067211614
Depreciation61607296116125131135144173176
Profit before Tax6486235146649009097451,1141,1891,3781,493
Tax %21.81%24.72%24.75%29.56%27.36%21.64%21.10%26.73%22.60%23.35%24.00%
Net Profit5074693874686547135888169201,0561,135
EPS57.5853.2543.9653.6075.0954.9645.8964.8373.6984.55—
Dividend Payout %22.57%0.00%20.29%24.25%12.57%11.38%14.99%78.67%38.00%33.12%—

COMPOUNDED SALES GROWTH

10 Years:
12%
5 Years:
14%
3 Years:
13%

COMPOUNDED PROFIT GROWTH

10 Years:
10%
5 Years:
10%
3 Years:
22%

STOCK PRICE CAGR

10 Years:
11%
5 Years:
20%
3 Years:
27%
1 Year:
37%

RETURN ON EQUITY

10 Years:
24%
5 Years:
23%
3 Years:
25%
Last Year:
25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2022

Jun 22

1:2

Bonus issue & Audited Results

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital18181717171725252525
1,5482,0222,2272,5812,9783,2473,3623,5363,7604,499
7353633132342944261
Trade Payables178250225362374327423463454544
72133384548709573860450834918
Total Liabilities1,8232,4262,9063,5724,1094,1974,7054,5045,1176,247
5891,0531,1681,4631,5321,5041,4961,4791,7621,867
Capital Work in Progress25361262132108153209256176258
1821907879176147535349464588
211351436496766791816828904939
00000001,2471,1831,854
Cash & Bank7093101205210212331131176105
5196788621,1971,3171,3901,317214452636
Total Assets1,8232,4262,9063,5724,1094,1974,7054,5045,1176,247

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
7604214936128078019437851,157529
Cash from Investing-383-256-223-224-282-74-56065-377-429
Cash from Financing-202-0-147-129-318-460-108-1,051-733-168
24254104-2428124-20147-68

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
66.2766.2666.2666.2666.2666.2566.2566.2563.48
8.369.119.268.868.868.537.978.267.68
17.4117.0917.0217.4817.5017.9018.5818.3621.80
0.010.010.010.010.010.010.010.010.00
7.947.527.457.397.387.327.197.127.03

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-31
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-31 - Ajanta Pharma Limited has informed the Exchange about

2026-08-31
Copy of Newspaper Publication

2026-08-31 - Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-05
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-05 - Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conference

2026-08-03
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-03 - Ajanta Pharma Limited has informed the Exchange about Transcript

2026-07-31
Copy of Newspaper Publication

2026-07-31 - Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Ajanta Pharma Limited has informed the Exchange about Link of Recording

2026-07-30
General Updates

2026-07-30 - Ajanta Pharma Limited has informed the Exchange about ESOP Allotment

2026-07-30
Dividend

2026-07-30 - Ajanta Pharma Limited has informed the Exchange that Board of Directors at its meeting held on July 30, 2026, declared Select Dividend of Rs. 32 per equity share.

2026-07-30
Record Date

2026-07-30 - Ajanta Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 05-Aug-2026.

News

Recent coverage and analyst commentary for AJANTPHARM

Loading news…

🤖

AI Stock Analyst

Ajanta Pharma Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login